emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университетemcardio-254Research ArticleОригинальные научные публикацииOriginal Scientific ResearchЭндотелиальная дисфункция при хронических обструктивных заболеваниях легкихEndothelial dysfunction in chronic obstructive pulmonary diseasesШолковаМ. В.SholkavaM. V.ДоценкоЭ. А.DotsenkoE. A.УО «Белорусский государственный медицинский университет»Belarusian State Medical University20191211202531539545Copyright © Шолкова М.В., Доценко Э.А., 20252025Шолкова М.В., Доценко Э.А.Sholkava M.V., Dotsenko E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/254

Нарушение функции эндотелия рассматривается как одно из общих звеньев коморбидности пульмонологических и сердечно-сосудистых заболеваний. Цель работы: оценить динамику показателей функции эндотелия у пациентов с хроническими обструктивными заболеваниями легких в сочетании с артериальной гипертензией (АГ), ишемической болезнью сердца (ИБС) и гиперлипидемией на фоне приема аторвастатина.

Endothelial dysfunction is considered as one of the links between pulmonary and cardiovascular diseases. To evaluate the dynamics of endothelial function in patients with dyslipidemia and chronic obstructive pulmonary diseases, receiving atorvastatin.

хроническая обструктивная болезнь легкихбронхиальная астмадислипидемияаторвастатинэндотелиальная дисфункцияchronic obstructive pulmonary diseaseasthmadyslipidemiaatorvastatinendothelial dysfunctionReferencesGuerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 2009, vol. 9, no. 5, рр. 409–416.Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 2009, vol. 9, no. 5, рр. 409–416.Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) [electronic resource]. Global Strаtegy for Asthma Management and Prevention, 2014. Available at: https://goldcopd.org/asthma-copd-asthma-copdoverlap-syndrome. (accessed 11.09.2017).Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) [electronic resource]. Global Strаtegy for Asthma Management and Prevention, 2014. Available at: https://goldcopd.org/asthma-copd-asthma-copdoverlap-syndrome. (accessed 11.09.2017).Rothnie K.J., Yan R., Smeeth L., Quint J.K. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis [electronic resource]. BMJ Open, 2015, vol. 5, no. 9, e007824. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26362660. (accessed 11.03.2018).Rothnie K.J., Yan R., Smeeth L., Quint J.K. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis [electronic resource]. BMJ Open, 2015, vol. 5, no. 9, e007824. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26362660. (accessed 11.03.2018).Tattersall M.C., Guo M., Korcarz C.E., Gepner A.D., Kaufman J.D., Liu K.J., Barr R.G., Donohue K.M., McClelland R.L., Delaney J.A., Stein J.H. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol, 2015, vol. 35, no. 6, pp. 1520–1525.Tattersall M.C., Guo M., Korcarz C.E., Gepner A.D., Kaufman J.D., Liu K.J., Barr R.G., Donohue K.M., McClelland R.L., Delaney J.A., Stein J.H. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol, 2015, vol. 35, no. 6, pp. 1520–1525.Khaddaj M.R., Mathew J.C, Kendrick D.J., Braun A.P. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci, 2017, vol. 54, no. 7-8, pp. 458–470.Khaddaj M.R., Mathew J.C, Kendrick D.J., Braun A.P. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci, 2017, vol. 54, no. 7-8, pp. 458–470.Maruhashi T., Soga J., Fujimura N., Idei N., Mikami S., Iwamoto Y., Kajikawa M., Matsumoto T., Hidaka T., Kihara Y., Chayama K., Noma K., Nakashima A., Goto C., Tomiyama H., Takase B., Yamashina A., Higashi Y. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart, 2013, vol. 99, no. 24, pp. 1837–1842.Maruhashi T., Soga J., Fujimura N., Idei N., Mikami S., Iwamoto Y., Kajikawa M., Matsumoto T., Hidaka T., Kihara Y., Chayama K., Noma K., Nakashima A., Goto C., Tomiyama H., Takase B., Yamashina A., Higashi Y. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart, 2013, vol. 99, no. 24, pp. 1837–1842.Goldenberg N.M., Kuebler W.M. Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Compr Physiol, 2015, vol. 5, no. 2, pp. 531–559.Goldenberg N.M., Kuebler W.M. Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Compr Physiol, 2015, vol. 5, no. 2, pp. 531–559.Ambrosino P., Lupoli R., Iervolino S., De Felice A., Pappone N., Storino A., Di Minno M.N.D. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med, 2017, vol. 12, no. 6, pp. 877–885.Ambrosino P., Lupoli R., Iervolino S., De Felice A., Pappone N., Storino A., Di Minno M.N.D. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med, 2017, vol. 12, no. 6, pp. 877–885.Dang H., Song B., Dong R., Zhang H. Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II. Exp Ther Med, 2018, vol. 16, no. 6, pp. 5286–5297.Dang H., Song B., Dong R., Zhang H. Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II. Exp Ther Med, 2018, vol. 16, no. 6, pp. 5286–5297.Oesterle A., Laufs U., Liao J.K. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 2017, vol. 120, no. 1, pp. 229–243.Oesterle A., Laufs U., Liao J.K. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 2017, vol. 120, no. 1, pp. 229–243.Margaritis M., Channon K.M., Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal, 2014, vol. 20, no. 8, pp. 1198–1215.Margaritis M., Channon K.M., Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal, 2014, vol. 20, no. 8, pp. 1198–1215.Zhang L., Gong D., Li S., Zhou X. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis, 2012, vol. 223, no. 1, pp.78–85.Zhang L., Gong D., Li S., Zhou X. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis, 2012, vol. 223, no. 1, pp.78–85.Chen J.H., Wu T., Yang L.K., Chen L., Zhu J., Li P.P., Hu X., Wang Y.H. Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage. Mol Med Rep, 2018, vol. 17, no. 1, pp. 1651–1659.Chen J.H., Wu T., Yang L.K., Chen L., Zhu J., Li P.P., Hu X., Wang Y.H. Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage. Mol Med Rep, 2018, vol. 17, no. 1, pp. 1651–1659.Lo C.C.W., Moosavi S.M., Bubb K.J. The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. Front Physiol. 2018, vol. 23, no. 9, pp. 1167. doi: 10.3389/fphys.2018.01167.Lo C.C.W., Moosavi S.M., Bubb K.J. The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. Front Physiol. 2018, vol. 23, no. 9, pp. 1167. doi: 10.3389/fphys.2018.01167.

The authors declare that there are no conflicts of interest present.